| Literature DB >> 17237032 |
Debbie Saslow1, Philip E Castle, J Thomas Cox, Diane D Davey, Mark H Einstein, Daron G Ferris, Sue J Goldie, Diane M Harper, Walter Kinney, Anna-Barbara Moscicki, Kenneth L Noller, Cosette M Wheeler, Terri Ades, Kimberly S Andrews, Mary K Doroshenk, Kelly Green Kahn, Christy Schmidt, Omar Shafey, Robert A Smith, Edward E Partridge, Francisco Garcia.
Abstract
The American Cancer Society (ACS) has developed guidelines for the use of the prophylactic human papillomavirus (HPV) vaccine for the prevention of cervical intraepithelial neoplasia and cervical cancer. These recommendations are based on a formal review of the available evidence. They address the use of prophylactic HPV vaccines, including who should be vaccinated and at what age, as well as a summary of policy and implementation issues. Implications for screening are also discussed.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17237032 DOI： 10.3322/canjclin.57.1.7
Source DB: PubMed Journal: CA Cancer J Clin ISSN： 0007-9235 Impact factor: 508.702